Heide Ford
Concepts (400)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Homeodomain Proteins | 30 | 2023 | 506 | 7.530 |
Why?
| | Protein Tyrosine Phosphatases | 22 | 2025 | 172 | 5.440 |
Why?
| | Breast Neoplasms | 26 | 2025 | 2234 | 3.690 |
Why?
| | Epithelial-Mesenchymal Transition | 13 | 2025 | 209 | 3.620 |
Why?
| | Gene Expression Regulation, Neoplastic | 29 | 2025 | 1396 | 3.300 |
Why?
| | Intracellular Signaling Peptides and Proteins | 15 | 2024 | 455 | 2.580 |
Why?
| | Nuclear Proteins | 15 | 2024 | 712 | 2.540 |
Why?
| | Triple Negative Breast Neoplasms | 6 | 2025 | 202 | 2.440 |
Why?
| | Neoplasms | 17 | 2025 | 2643 | 2.060 |
Why?
| | Transforming Growth Factor beta | 7 | 2012 | 480 | 2.030 |
Why?
| | Neoplasm Metastasis | 17 | 2025 | 657 | 2.020 |
Why?
| | Cell Line, Tumor | 38 | 2025 | 3406 | 2.010 |
Why?
| | Neoplastic Stem Cells | 10 | 2025 | 399 | 1.930 |
Why?
| | MicroRNAs | 6 | 2018 | 692 | 1.700 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 6 | 2017 | 51 | 1.580 |
Why?
| | Vascular Endothelial Growth Factor C | 3 | 2020 | 17 | 1.540 |
Why?
| | Cell Transformation, Neoplastic | 6 | 2015 | 327 | 1.360 |
Why?
| | Signal Transduction | 20 | 2025 | 5077 | 1.250 |
Why?
| | Drug Resistance, Neoplasm | 9 | 2017 | 800 | 1.240 |
Why?
| | Muscle Development | 2 | 2022 | 111 | 1.120 |
Why?
| | DNA-Binding Proteins | 7 | 2025 | 1501 | 1.110 |
Why?
| | Sarcoma, Ewing | 2 | 2023 | 96 | 1.100 |
Why?
| | Up-Regulation | 9 | 2018 | 844 | 1.050 |
Why?
| | Protein Phosphatase 2 | 3 | 2025 | 41 | 1.010 |
Why?
| | Cell Plasticity | 2 | 2025 | 35 | 0.960 |
Why?
| | Zebrafish Proteins | 2 | 2022 | 286 | 0.950 |
Why?
| | Transcription Factors | 7 | 2022 | 1718 | 0.940 |
Why?
| | Mammary Glands, Human | 4 | 2010 | 64 | 0.920 |
Why?
| | Rhabdomyosarcoma | 2 | 2024 | 72 | 0.920 |
Why?
| | Chemokine CCL2 | 1 | 2025 | 115 | 0.920 |
Why?
| | Animals | 50 | 2025 | 36850 | 0.890 |
Why?
| | Oncogene Proteins, Fusion | 4 | 2024 | 214 | 0.870 |
Why?
| | Disease Progression | 5 | 2025 | 2751 | 0.840 |
Why?
| | Proto-Oncogene Proteins c-myc | 3 | 2025 | 139 | 0.780 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 152 | 0.750 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 443 | 0.740 |
Why?
| | Medulloblastoma | 1 | 2023 | 193 | 0.730 |
Why?
| | NF-kappa B | 1 | 2025 | 691 | 0.710 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 3 | 2017 | 30 | 0.710 |
Why?
| | Neuropilin-2 | 1 | 2020 | 3 | 0.710 |
Why?
| | Antineoplastic Agents | 9 | 2024 | 2123 | 0.700 |
Why?
| | Mammary Neoplasms, Experimental | 5 | 2012 | 68 | 0.690 |
Why?
| | Cell Transdifferentiation | 2 | 2010 | 31 | 0.670 |
Why?
| | Mice | 30 | 2025 | 17759 | 0.660 |
Why?
| | Humans | 75 | 2025 | 136803 | 0.650 |
Why?
| | Mice, SCID | 9 | 2019 | 366 | 0.640 |
Why?
| | Cadherins | 2 | 2014 | 205 | 0.630 |
Why?
| | Breast | 1 | 2020 | 149 | 0.620 |
Why?
| | Pluripotent Stem Cells | 1 | 2020 | 79 | 0.620 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 2 | 2016 | 65 | 0.610 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 2 | 2023 | 25 | 0.600 |
Why?
| | RNA-Binding Protein EWS | 2 | 2023 | 26 | 0.600 |
Why?
| | Transcriptional Activation | 3 | 2018 | 378 | 0.590 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2018 | 15 | 0.590 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 61 | 0.580 |
Why?
| | Neoplasm Proteins | 3 | 2018 | 434 | 0.580 |
Why?
| | Epithelial Cells | 5 | 2012 | 1094 | 0.580 |
Why?
| | Receptor, Notch1 | 1 | 2018 | 64 | 0.570 |
Why?
| | Zinc Finger Protein GLI1 | 1 | 2017 | 25 | 0.550 |
Why?
| | Mice, Inbred NOD | 6 | 2019 | 600 | 0.550 |
Why?
| | Cell Proliferation | 12 | 2024 | 2476 | 0.540 |
Why?
| | Anion Transport Proteins | 1 | 2017 | 9 | 0.530 |
Why?
| | Paracrine Communication | 1 | 2017 | 65 | 0.530 |
Why?
| | Female | 36 | 2025 | 72816 | 0.520 |
Why?
| | Genetic Heterogeneity | 1 | 2016 | 59 | 0.510 |
Why?
| | Down-Regulation | 2 | 2015 | 656 | 0.510 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 217 | 0.500 |
Why?
| | Cell Differentiation | 9 | 2022 | 1982 | 0.480 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2019 | 1058 | 0.480 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 93 | 0.480 |
Why?
| | Twist-Related Protein 1 | 1 | 2015 | 9 | 0.470 |
Why?
| | Mammary Glands, Animal | 3 | 2010 | 129 | 0.460 |
Why?
| | Cell Cycle | 4 | 2013 | 601 | 0.460 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 595 | 0.460 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2016 | 528 | 0.460 |
Why?
| | Mesoderm | 3 | 2009 | 144 | 0.450 |
Why?
| | Tumor Microenvironment | 3 | 2025 | 672 | 0.440 |
Why?
| | Epithelium | 3 | 2009 | 311 | 0.440 |
Why?
| | Receptors, Transforming Growth Factor beta | 2 | 2012 | 59 | 0.430 |
Why?
| | Protein Binding | 9 | 2025 | 2216 | 0.430 |
Why?
| | Neoplasm Transplantation | 6 | 2014 | 257 | 0.430 |
Why?
| | MCF-7 Cells | 4 | 2020 | 124 | 0.420 |
Why?
| | Branchio-Oto-Renal Syndrome | 2 | 2013 | 6 | 0.420 |
Why?
| | Interferons | 2 | 2025 | 202 | 0.410 |
Why?
| | Lung Neoplasms | 4 | 2019 | 2489 | 0.410 |
Why?
| | Molecular Targeted Therapy | 2 | 2015 | 411 | 0.400 |
Why?
| | Transcription, Genetic | 3 | 2014 | 1455 | 0.400 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2017 | 858 | 0.390 |
Why?
| | Superoxide Dismutase | 1 | 2014 | 346 | 0.390 |
Why?
| | Lymphangiogenesis | 1 | 2012 | 27 | 0.380 |
Why?
| | Genes, Tumor Suppressor | 1 | 2012 | 86 | 0.380 |
Why?
| | Smad7 Protein | 1 | 2012 | 19 | 0.380 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 171 | 0.360 |
Why?
| | Mice, Nude | 7 | 2017 | 696 | 0.350 |
Why?
| | Genes, Homeobox | 3 | 2022 | 50 | 0.330 |
Why?
| | Bone Neoplasms | 1 | 2012 | 248 | 0.320 |
Why?
| | Apoptosis | 4 | 2019 | 2552 | 0.320 |
Why?
| | Cyclin A | 3 | 2009 | 17 | 0.320 |
Why?
| | Mice, Inbred BALB C | 4 | 2019 | 1269 | 0.310 |
Why?
| | Embryonic Development | 1 | 2010 | 119 | 0.310 |
Why?
| | Enzyme Inhibitors | 7 | 2024 | 839 | 0.310 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2025 | 868 | 0.300 |
Why?
| | Prognosis | 6 | 2019 | 4013 | 0.290 |
Why?
| | Cell Movement | 5 | 2020 | 968 | 0.290 |
Why?
| | Tyrosine | 3 | 2024 | 222 | 0.280 |
Why?
| | Genomic Instability | 1 | 2008 | 53 | 0.280 |
Why?
| | Gene Regulatory Networks | 2 | 2023 | 304 | 0.270 |
Why?
| | Ovarian Neoplasms | 3 | 2012 | 562 | 0.260 |
Why?
| | Heterografts | 3 | 2017 | 138 | 0.250 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2012 | 1684 | 0.250 |
Why?
| | Retina | 1 | 2008 | 298 | 0.240 |
Why?
| | Gene Knockdown Techniques | 3 | 2016 | 327 | 0.240 |
Why?
| | STAT1 Transcription Factor | 1 | 2025 | 73 | 0.230 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 1 | 2024 | 25 | 0.230 |
Why?
| | Gene Amplification | 1 | 2005 | 104 | 0.230 |
Why?
| | Neoplasm Invasiveness | 3 | 2024 | 507 | 0.220 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2024 | 86 | 0.220 |
Why?
| | Myosins | 1 | 2024 | 132 | 0.220 |
Why?
| | Rosaniline Dyes | 1 | 2024 | 13 | 0.220 |
Why?
| | Kaplan-Meier Estimate | 2 | 2020 | 888 | 0.220 |
Why?
| | Zebrafish | 2 | 2022 | 495 | 0.210 |
Why?
| | Protein Stability | 2 | 2018 | 176 | 0.210 |
Why?
| | Peptides | 3 | 2025 | 981 | 0.210 |
Why?
| | Cell Hypoxia | 1 | 2024 | 226 | 0.210 |
Why?
| | Eye Proteins | 1 | 2024 | 92 | 0.210 |
Why?
| | Drug Design | 1 | 2024 | 167 | 0.210 |
Why?
| | Gene Expression Profiling | 4 | 2012 | 1772 | 0.200 |
Why?
| | Integrins | 1 | 2023 | 95 | 0.200 |
Why?
| | Models, Biological | 4 | 2017 | 1773 | 0.190 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 256 | 0.190 |
Why?
| | Myogenin | 1 | 2022 | 16 | 0.190 |
Why?
| | MyoD Protein | 1 | 2022 | 35 | 0.190 |
Why?
| | Rhabdomyosarcoma, Embryonal | 1 | 2022 | 22 | 0.190 |
Why?
| | Immunohistochemistry | 3 | 2018 | 1733 | 0.190 |
Why?
| | HEK293 Cells | 3 | 2024 | 729 | 0.190 |
Why?
| | Transplantation, Heterologous | 4 | 2012 | 194 | 0.180 |
Why?
| | Cell Survival | 2 | 2017 | 1116 | 0.180 |
Why?
| | Brain Neoplasms | 3 | 2024 | 1235 | 0.180 |
Why?
| | Tumor Cells, Cultured | 4 | 2019 | 953 | 0.180 |
Why?
| | Small Molecule Libraries | 2 | 2019 | 94 | 0.170 |
Why?
| | Chromatin | 1 | 2024 | 519 | 0.170 |
Why?
| | Cell Dedifferentiation | 2 | 2010 | 32 | 0.170 |
Why?
| | BRCA1 Protein | 1 | 2020 | 76 | 0.160 |
Why?
| | Oxygen | 1 | 2024 | 930 | 0.160 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 195 | 0.160 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 13 | 0.150 |
Why?
| | Prostatic Neoplasms | 2 | 2024 | 1034 | 0.150 |
Why?
| | Cyclin A1 | 3 | 2009 | 5 | 0.150 |
Why?
| | Phosphorylation | 3 | 2024 | 1758 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 975 | 0.150 |
Why?
| | Antigens, CD | 2 | 2014 | 521 | 0.140 |
Why?
| | Glioblastoma | 1 | 2021 | 343 | 0.140 |
Why?
| | Mutation | 1 | 2009 | 3947 | 0.140 |
Why?
| | Cell Growth Processes | 2 | 2008 | 52 | 0.140 |
Why?
| | RNA, Small Interfering | 2 | 2017 | 622 | 0.140 |
Why?
| | Veratrum Alkaloids | 1 | 2017 | 19 | 0.140 |
Why?
| | Blotting, Western | 3 | 2011 | 1225 | 0.140 |
Why?
| | Maxilla | 1 | 2017 | 37 | 0.140 |
Why?
| | RNA, Messenger | 3 | 2018 | 2831 | 0.130 |
Why?
| | Basigin | 1 | 2017 | 25 | 0.130 |
Why?
| | Proteolysis | 2 | 2017 | 177 | 0.130 |
Why?
| | Carbolines | 1 | 1996 | 32 | 0.130 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 1996 | 26 | 0.130 |
Why?
| | Promoter Regions, Genetic | 3 | 2010 | 1249 | 0.130 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.120 |
Why?
| | Clone Cells | 1 | 2016 | 266 | 0.120 |
Why?
| | Protein Structure, Tertiary | 2 | 2009 | 860 | 0.120 |
Why?
| | Multigene Family | 2 | 2008 | 198 | 0.120 |
Why?
| | Biphenyl Compounds | 1 | 1996 | 63 | 0.120 |
Why?
| | Oxidoreductases | 1 | 1996 | 92 | 0.120 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 162 | 0.120 |
Why?
| | Allosteric Regulation | 3 | 2024 | 97 | 0.120 |
Why?
| | Epigenesis, Genetic | 2 | 2024 | 657 | 0.120 |
Why?
| | Endothelin-1 | 1 | 2017 | 182 | 0.120 |
Why?
| | Cytidine | 2 | 1993 | 8 | 0.120 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 436 | 0.120 |
Why?
| | Tumor Burden | 2 | 2017 | 309 | 0.120 |
Why?
| | Trans-Activators | 2 | 2010 | 398 | 0.120 |
Why?
| | Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 6 | 0.120 |
Why?
| | Structure-Activity Relationship | 3 | 2024 | 570 | 0.120 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2022 | 654 | 0.110 |
Why?
| | Cell Nucleus | 2 | 2009 | 617 | 0.110 |
Why?
| | Claudins | 1 | 2014 | 25 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2015 | 134 | 0.110 |
Why?
| | Mass Spectrometry | 1 | 2018 | 738 | 0.110 |
Why?
| | Gene Expression | 3 | 2009 | 1500 | 0.110 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 92 | 0.110 |
Why?
| | Genes, MHC Class I | 2 | 2005 | 35 | 0.110 |
Why?
| | Survival Rate | 1 | 2019 | 1964 | 0.110 |
Why?
| | Autophagy | 1 | 2016 | 280 | 0.110 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2014 | 100 | 0.110 |
Why?
| | RNA Interference | 2 | 2017 | 466 | 0.110 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2605 | 0.110 |
Why?
| | Transfection | 3 | 2017 | 941 | 0.110 |
Why?
| | Pyrimidines | 1 | 2017 | 470 | 0.110 |
Why?
| | Biomedical Research | 1 | 2020 | 688 | 0.100 |
Why?
| | G1 Phase | 1 | 2013 | 71 | 0.100 |
Why?
| | Child | 2 | 2023 | 21819 | 0.100 |
Why?
| | Pyridines | 1 | 2017 | 506 | 0.100 |
Why?
| | Cyclin-Dependent Kinase 6 | 1 | 2013 | 42 | 0.100 |
Why?
| | Amino Acid Sequence | 6 | 2014 | 2138 | 0.100 |
Why?
| | Disease-Free Survival | 1 | 2014 | 686 | 0.100 |
Why?
| | Cluster Analysis | 2 | 2012 | 497 | 0.100 |
Why?
| | Antibodies, Neoplasm | 1 | 2012 | 34 | 0.090 |
Why?
| | Neuroglia | 1 | 2013 | 173 | 0.090 |
Why?
| | Etoposide | 1 | 2012 | 158 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 913 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 766 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1272 | 0.090 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2017 | 155 | 0.090 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 621 | 0.090 |
Why?
| | Tissue Array Analysis | 1 | 2011 | 57 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2024 | 2052 | 0.090 |
Why?
| | Metabolic Networks and Pathways | 1 | 2012 | 180 | 0.090 |
Why?
| | Repressor Proteins | 1 | 2014 | 427 | 0.090 |
Why?
| | Proteasome Inhibitors | 1 | 2011 | 46 | 0.090 |
Why?
| | Cell Death | 2 | 2021 | 372 | 0.090 |
Why?
| | DNA Damage | 2 | 2017 | 420 | 0.090 |
Why?
| | Energy Metabolism | 1 | 2017 | 919 | 0.090 |
Why?
| | Antioxidants | 1 | 2014 | 584 | 0.090 |
Why?
| | Lymphatic Metastasis | 1 | 2012 | 351 | 0.090 |
Why?
| | Doxorubicin | 1 | 2012 | 362 | 0.080 |
Why?
| | Protein Domains | 2 | 2024 | 289 | 0.080 |
Why?
| | Antigens, Differentiation | 1 | 2010 | 83 | 0.080 |
Why?
| | Metaplasia | 1 | 2009 | 60 | 0.080 |
Why?
| | Smad3 Protein | 1 | 2009 | 43 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5106 | 0.080 |
Why?
| | Lymphoma | 1 | 2011 | 208 | 0.080 |
Why?
| | Salivary Proteins and Peptides | 1 | 2009 | 14 | 0.080 |
Why?
| | Submandibular Gland | 1 | 2009 | 20 | 0.080 |
Why?
| | Lymphocytes | 1 | 1991 | 393 | 0.080 |
Why?
| | Mutant Proteins | 1 | 2009 | 101 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 935 | 0.070 |
Why?
| | Glioma | 1 | 2013 | 395 | 0.070 |
Why?
| | Lactation | 1 | 2010 | 181 | 0.070 |
Why?
| | Protein Structure, Secondary | 1 | 2009 | 374 | 0.070 |
Why?
| | Amino Acid Substitution | 1 | 2009 | 306 | 0.070 |
Why?
| | Clinical Trials as Topic | 2 | 2012 | 1044 | 0.070 |
Why?
| | Eye Neoplasms | 1 | 2008 | 18 | 0.070 |
Why?
| | NIH 3T3 Cells | 1 | 2008 | 144 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2014 | 1314 | 0.070 |
Why?
| | Cell Line | 3 | 2014 | 2838 | 0.070 |
Why?
| | Protein Transport | 1 | 2009 | 443 | 0.070 |
Why?
| | Ubiquitin | 1 | 2006 | 66 | 0.060 |
Why?
| | Amino Acid Motifs | 1 | 2006 | 225 | 0.060 |
Why?
| | DNA | 2 | 2009 | 1458 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2012 | 4282 | 0.060 |
Why?
| | Models, Molecular | 4 | 2019 | 1570 | 0.060 |
Why?
| | Crystallography, X-Ray | 2 | 2019 | 476 | 0.060 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2005 | 21 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 58 | 0.060 |
Why?
| | Ovary | 1 | 2007 | 221 | 0.060 |
Why?
| | PAX3 Transcription Factor | 1 | 2024 | 17 | 0.060 |
Why?
| | Chickens | 1 | 2005 | 191 | 0.060 |
Why?
| | Molecular Structure | 2 | 2024 | 489 | 0.060 |
Why?
| | Paired Box Transcription Factors | 1 | 2024 | 46 | 0.060 |
Why?
| | Precipitin Tests | 1 | 2004 | 100 | 0.060 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 62 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2025 | 190 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2009 | 2163 | 0.050 |
Why?
| | Phylogeny | 2 | 2005 | 903 | 0.050 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2024 | 195 | 0.050 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2003 | 32 | 0.050 |
Why?
| | Dogfish | 1 | 2003 | 4 | 0.050 |
Why?
| | Cyclin D1 | 1 | 2003 | 68 | 0.050 |
Why?
| | Cell Lineage | 1 | 2025 | 347 | 0.050 |
Why?
| | Molecular Sequence Data | 5 | 2014 | 2894 | 0.050 |
Why?
| | Fibroblasts | 1 | 2008 | 993 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 271 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 452 | 0.050 |
Why?
| | Cell Division | 1 | 2004 | 796 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 311 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2010 | 5750 | 0.050 |
Why?
| | Neovascularization, Pathologic | 1 | 2004 | 301 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2005 | 488 | 0.040 |
Why?
| | Kinetics | 2 | 2012 | 1664 | 0.040 |
Why?
| | Developmental Biology | 1 | 2020 | 22 | 0.040 |
Why?
| | Neural Stem Cells | 1 | 2021 | 155 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 552 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2014 | 385 | 0.040 |
Why?
| | Terminology as Topic | 1 | 2020 | 216 | 0.040 |
Why?
| | Male | 6 | 2024 | 67330 | 0.030 |
Why?
| | Sp7 Transcription Factor | 1 | 2017 | 7 | 0.030 |
Why?
| | Zygoma | 1 | 2017 | 8 | 0.030 |
Why?
| | Serrate-Jagged Proteins | 1 | 2017 | 27 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2012 | 10748 | 0.030 |
Why?
| | Branchial Region | 1 | 2017 | 36 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 22 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 11 | 0.030 |
Why?
| | Receptor, Endothelin A | 1 | 2017 | 65 | 0.030 |
Why?
| | Pregnancy | 1 | 2010 | 6729 | 0.030 |
Why?
| | Consensus | 1 | 2020 | 678 | 0.030 |
Why?
| | Orotic Acid | 1 | 1996 | 2 | 0.030 |
Why?
| | Craniofacial Abnormalities | 1 | 2017 | 72 | 0.030 |
Why?
| | Autophagy-Related Proteins | 1 | 2016 | 46 | 0.030 |
Why?
| | DNA Primers | 3 | 2005 | 514 | 0.030 |
Why?
| | Diphtheria Toxin | 1 | 2016 | 66 | 0.030 |
Why?
| | Receptors, Notch | 1 | 2017 | 88 | 0.030 |
Why?
| | Ribonucleotides | 1 | 1996 | 26 | 0.030 |
Why?
| | Body Patterning | 1 | 2017 | 132 | 0.030 |
Why?
| | Integrases | 1 | 2017 | 120 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2017 | 232 | 0.030 |
Why?
| | Phosphotyrosine | 1 | 1996 | 39 | 0.030 |
Why?
| | Neural Crest | 1 | 2017 | 116 | 0.030 |
Why?
| | Aspartic Acid | 1 | 1996 | 79 | 0.030 |
Why?
| | Epidermal Growth Factor | 1 | 2016 | 175 | 0.030 |
Why?
| | Sodium Bicarbonate | 1 | 1996 | 45 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 283 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2009 | 431 | 0.030 |
Why?
| | DNA Repair | 1 | 2017 | 231 | 0.030 |
Why?
| | Cytidine Triphosphate | 2 | 1993 | 16 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2017 | 466 | 0.030 |
Why?
| | Adult | 3 | 2015 | 37643 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 390 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 249 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2014 | 86 | 0.030 |
Why?
| | Carbon-Nitrogen Ligases | 1 | 1993 | 5 | 0.030 |
Why?
| | Leukemia L1210 | 1 | 1993 | 8 | 0.030 |
Why?
| | Central Nervous System Neoplasms | 1 | 1996 | 156 | 0.030 |
Why?
| | Calorimetry | 1 | 2014 | 70 | 0.030 |
Why?
| | Leukemia | 1 | 1996 | 238 | 0.030 |
Why?
| | Colonic Neoplasms | 1 | 1996 | 256 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2016 | 664 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 113 | 0.030 |
Why?
| | Magnesium | 1 | 2014 | 156 | 0.030 |
Why?
| | Zinc Finger E-box-Binding Homeobox 1 | 1 | 2013 | 24 | 0.030 |
Why?
| | Amino Acids | 1 | 2017 | 497 | 0.030 |
Why?
| | Phenylhydrazines | 1 | 2012 | 5 | 0.020 |
Why?
| | Miniaturization | 1 | 2012 | 22 | 0.020 |
Why?
| | Protein Phosphatase 2C | 1 | 2012 | 15 | 0.020 |
Why?
| | Time Factors | 2 | 2017 | 6809 | 0.020 |
Why?
| | Fluoresceins | 1 | 2012 | 47 | 0.020 |
Why?
| | Enzyme Assays | 1 | 2012 | 24 | 0.020 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 47 | 0.020 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2012 | 67 | 0.020 |
Why?
| | Spleen | 2 | 2005 | 514 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2012 | 168 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 340 | 0.020 |
Why?
| | Antibody Specificity | 1 | 2012 | 189 | 0.020 |
Why?
| | Kidney Neoplasms | 1 | 1996 | 401 | 0.020 |
Why?
| | DNA Fragmentation | 1 | 2011 | 41 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 59 | 0.020 |
Why?
| | Sequence Analysis, DNA | 2 | 2005 | 809 | 0.020 |
Why?
| | Software | 1 | 1996 | 665 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2013 | 337 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2012 | 159 | 0.020 |
Why?
| | Drug Synergism | 1 | 2011 | 383 | 0.020 |
Why?
| | Mitochondria | 1 | 1996 | 946 | 0.020 |
Why?
| | Brain | 1 | 2021 | 2664 | 0.020 |
Why?
| | Melanoma | 1 | 1996 | 757 | 0.020 |
Why?
| | HIV-1 | 1 | 1995 | 863 | 0.020 |
Why?
| | Azacitidine | 1 | 1990 | 140 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 1991 | 430 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2009 | 330 | 0.020 |
Why?
| | RNA | 2 | 1993 | 921 | 0.020 |
Why?
| | Organ Size | 1 | 2009 | 477 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 1996 | 1076 | 0.020 |
Why?
| | Base Sequence | 2 | 2005 | 2179 | 0.020 |
Why?
| | Bursa of Fabricius | 1 | 2005 | 2 | 0.020 |
Why?
| | Blotting, Southern | 1 | 2005 | 72 | 0.010 |
Why?
| | Sequence Homology | 1 | 2005 | 40 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2005 | 200 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2005 | 239 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2005 | 342 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2005 | 523 | 0.010 |
Why?
| | Databases, Genetic | 1 | 2003 | 237 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2003 | 534 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2009 | 3009 | 0.010 |
Why?
| | HIV Infections | 1 | 1995 | 2828 | 0.010 |
Why?
| | Biological Evolution | 1 | 2003 | 467 | 0.010 |
Why?
| | Genetic Variation | 1 | 2003 | 985 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2005 | 2184 | 0.010 |
Why?
| | Fluorine | 1 | 1996 | 16 | 0.010 |
Why?
| | Chemistry, Physical | 1 | 1996 | 37 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1996 | 83 | 0.010 |
Why?
| | src Homology Domains | 1 | 1996 | 41 | 0.010 |
Why?
| | Ions | 1 | 1996 | 70 | 0.010 |
Why?
| | Cricetinae | 1 | 1996 | 289 | 0.010 |
Why?
| | Dideoxyadenosine | 1 | 1995 | 3 | 0.010 |
Why?
| | Genes, env | 1 | 1995 | 5 | 0.010 |
Why?
| | Proviruses | 1 | 1995 | 14 | 0.010 |
Why?
| | Lymphocyte Transfusion | 1 | 1995 | 21 | 0.010 |
Why?
| | Lymphocyte Count | 1 | 1995 | 150 | 0.010 |
Why?
| | Viremia | 1 | 1995 | 138 | 0.010 |
Why?
| | Deamination | 1 | 1993 | 6 | 0.010 |
Why?
| | Middle Aged | 2 | 2013 | 33239 | 0.010 |
Why?
| | Ligases | 1 | 1993 | 32 | 0.010 |
Why?
| | Drug Resistance | 1 | 1993 | 169 | 0.010 |
Why?
| | DNA, Viral | 1 | 1995 | 363 | 0.010 |
Why?
| | Immunotherapy, Adoptive | 1 | 1995 | 321 | 0.010 |
Why?
| | Drug Evaluation | 1 | 1990 | 84 | 0.010 |
Why?
| | Leukopenia | 1 | 1990 | 31 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1995 | 1242 | 0.010 |
Why?
| | Antiviral Agents | 1 | 1995 | 739 | 0.000 |
Why?
| | Neutropenia | 1 | 1990 | 146 | 0.000 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 1995 | 1095 | 0.000 |
Why?
| | Antibodies, Monoclonal | 1 | 1995 | 1430 | 0.000 |
Why?
| | Thrombocytopenia | 1 | 1990 | 198 | 0.000 |
Why?
| | Drug Administration Schedule | 1 | 1990 | 785 | 0.000 |
Why?
| | Aged | 1 | 1990 | 23808 | 0.000 |
Why?
|
|
Ford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|